Category Archives: BioInformatics

Bioinformatics 8 By: John Yoder … Continue reading →

Biostatistics and Bioinformatics Lecture 8 Biostatistics and Bioinformatics Lecture 7. By: Stuart Brown … Continue reading →

Bioinformatics Toolbox Overview Read, analyze, and visualize genomic and proteomic data using Bioinformatics Toolbox. By: MATLAB … Continue reading →

GenapSys has appointed Mark Pratt as vice president of product development. Most recently, Pratt was senior director of accuracy R&D at Personalis. Before that, he served at Illumina, where he was responsible for engineering research, including holding leadership positions in the development of the HiSeq and MiSeq systems. The Personalized Medicine Coalition announced that Daryl Pritchard will be its new VP of science policy, in charge of promoting the organization's science-related policies and of raising awareness of precision healthcare issues among policymakers, providers, and patients. Before joining PMC, Pritchard was director of policy research at the National Pharmaceutical Council; director of research programs advocacy and personalized medicine at the Biotechnology Industry Organization; and the director of government affairs for the American Association for Dental Research. Nabsys has appointed Steve Lombardi to president, CEO, and to its board of directors. Previously, he was CEO of Real Time Genomics, and before that he was CEO of Helicos BioSciences. He has also served as senior vice president of Affymetrix and vice president of genetic analysis at Applied Biosystems. Roche said this week that Arthur Levinson has resigned from its board of directors, effective immediately. The drugmaker said Levinson, who was chairman and CEO … Continue reading →

DEFINITION of 'Bioinformatics' The application of computational technology to handle the rapidly growing repository of information related to molecular biology. Bioinformatics combines different fields of study, including computer sciences, molecular biology, biotechnology, statistics, and engineering. It is particularly useful for managing and analyzing large sets of data, such as those generated by the fields of genomics and proteomics. While the field of bioinformatics has existed for decades, the catalyst for its rapid growth in the current millennium came from the Human Genome Project, a landmark project completed in April 2003 that made available for the first time the complete genetic blueprint of a human being. Bioinformatics finds application in a growing number of areas, such as gene sequencing, gene expression studies and drug discovery. Bioinformatics has three main objectives The advent and rapid rise of bioinformatics has been due to the massive increases in computing power and laboratory technology in recent years. These advances have made it possible to process and analyze the digital information DNA, genes and genomes at the heart of life itself. As bioinformatics can be used in any system where information can be represented digitally, it can be applied across the entire spectrum of living organisms, … Continue reading →

(PRWEB) September 29, 2014 Within the field of bioinformatics, biomedical scientists and organizations struggle with multiple challenges such as how to allow biomedical scientists to analyze data by themselves and how to utilize resources in an optimal way. Qlucore, provider of the bioinformatics software program Qlucore Omics Explorer, has developed a new educational webinar to address these challenges Make new discoveries - with Qlucore's visualization based software. The webinar will be broadcast live on October 2nd 2014 at 7:00am Pacific Time. Qlucore Omics Explorer is a user-friendly program which allows users to be up and running, performing data analysis, in a matter of hours. This reduces project lead times considerably and lets scientists spend more time on testing theories and alternative hypothesis. Bioinformatics expert, Dr. Magnus Fontes, PhD will be presenting. Dr. Fontes is a Co-Founder of Qlucore and Professor of Mathematics at Lund University. He is an expert in visualization and biomedical data analysis and is currently visiting professor at Institut Pasteur in Paris. He is the Vice-Chair of the Swedish National Committee for Mathematics at the Royal Swedish Academy of Science and a member of the Executive Committee of EU-Maths-In. From 2003-2014 he was Head of the Centre … Continue reading →

pritiranjan sasamal nou bioinformatics pritiranjan sasamal giving his own campening for the post of editor banani in north orissa university student election 2014. By: north orissa university … Continue reading →

Bangalore-based junior bioinformatics associate Costerwell Khyriem on deciphering the complexities of life as a career option ADVANCEMENTS IN technology supplement advancement in science. Over the past three decades, biological scientists has diverge from a limited based research where they can focus on a few entity of their interest to a massive multiple entity based research. The mammoth quantity of data and information generated from such studies is too vast for humans to analyse. Hence, the requirement of a computer aided fast but robust dissection of the such data. This approach gave rise to a whole new field in bioscience bioinformatics and computational biology. It is field with a whole new approach where an aspirant need not perform the chemical mixing portion of the experiment but he/she analyse the data using the quadrangle machine. Of course, to be a bioinformatician or a computational biologist one must learn how to use the computer beyond typing, clicking and opening applications. One must learn how to write programs and make computers do the work for them. A bioinformatician or a computational biologist is required to learn languages used in giving instructions to computer to make it perform tasks of your desire; C, C++, Perl, … Continue reading →

Contact Information Available for logged-in reporters only Newswise The Ebola epidemic could claim hundreds of thousands of lives and infect more than 1.4 million people by the end of January, according to a statistical forecast released this week by the U.S. Centers for Disease Control and Prevention. The CDC forecast supports the drastically higher projections released earlier by a group of scientists, including epidemiologists with the Virginia Bioinformatics Institute, who modeled the Ebola spread as part of a National Institutes of Health-sponsored project called Midas, short for Models of Infectious Disease Agent Study. The effort is also supported by the federal Defense Threat Reduction Agency. Before the scientists released results, the outbreak in West Africa was expected to be under control in nine months with only about 20,000 total cases. But modeling showed 20,000 people could be infected in just a single month. The predictions could change dramatically if public health efforts become effective, but based on the viruss current uncontrolled spread, numbers of people infected could skyrocket. If the disease keeps spreading as it has been we estimate there could be hundreds of thousands of cases by the end of the year in Liberia alone, said Bryan Lewis, a … Continue reading →

The Personalized Medicine Coalition announced that Daryl Pritchard will be its new VP of science policy, in charge of promoting the organization's science-related policies and of raising awareness of precision healthcare issues among policymakers, providers, and patients. Before joining PMC, Pritchard was director of policy research at the National Pharmaceutical Council; director of research programs advocacy and personalized medicine at the Biotechnology Industry Organization; and the director of government affairs for the American Association for Dental Research. Nabsys has appointed Steve Lombardi to president, CEO, and to its board of directors. Previously, he was CEO of Real Time Genomics, and before that he was CEO of Helicos BioSciences. He has also served as senior vice president of Affymetrix and vice president of genetic analysis at Applied Biosystems. Roche said this week that Arthur Levinson has resigned from its board of directors, effective immediately. The drugmaker said Levinson, who was chairman and CEO at Genentech from 1999 to 2014, made the decision to avoid any conflict with his post as CEO at Calico, a Google-backed startup. Levinson has served on Roche's board since 2010. Sanford Burnham Medical Research Institute said this week it has named Perry Nisen as its CEO and … Continue reading →